Biology Agriculture Aquaculture Horticulture Postharvest Forestry Geography Environment Health





Lipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey

submitted by marphriim 2 years and 2 months ago
Treatment of hypercholesterolaemia in Asia is rarely evaluated on a large scale, and data on treatment outcome are scarce. The Pan-Asian CEPHEUS study aimed to assess low-density lipoprotein cholesterol (LDL-C) goal attainment among patients on lipid-lowering therapy. This survey was conducted in eight Asian countries. Hypercholesterolaemic patients aged ≥18 years who had been on lipid-lowering treatment for ≥3 months (stable medication for ≥6 weeks) were recruited, and lipid concentrations were measured. Demographic and other clinically relevant information were collected, and the cardiovascular risk of each patient was determined. Definitions and criteria set by the updated 24 National Cholesterol Education Program guidelines were applied. In this survey, 51 physicians enrolled 864 patients, of whom 7281 were included in the final analysis. The mean age was 6years, 44.4% were female, and 85.1% were on statin monotherapy. LDL-C goal attainment was reported in 49.1% of patients overall, including 51.2% of primary and 48.7% of secondary prevention patients, and 36.6% of patients with familial hypercholesterolaemia. The LDL-C goal was attained in 75.4% of moderate risk, 55.4% of high risk, and only 34.9% of very high-risk patients. Goal attainment was directly related to age and inversely related to cardiovascular risk and baseline LDL-C. A large proportion of Asian hypercholesterolaemic patients on lipid-lowering drugs are not at recommended LDL-C levels and remain at risk for cardiovascular disease. Given the proven efficacy of lipid-lowering drugs in the reduction of LDL-C, there is room for further optimization of treatments to maximize benefits and improve outcomes.


Topic: Health

Add your comment

Please Login or Signup to leave a comment

Related stories

Cross-Sectional Survey to Assess the Status of Lipid Management in High-Risk Patients With Dyslipidemia: Clinical Impact of Combination Therapy With Ezetimibe
submitted by yoro 1 year and 9 months ago - Topic: Health
Previous retrospective surveys have shown that lipid management goals are well achieved in patients with dyslipidemia at relatively low risk for atherosclerotic diseases. However, more than half of patients in high-risk groups have not achieved the management goals. Since these surveys, newer medications, including rosuvastatin and ezetimibe, have emerged in clinical practice that may influence...

Lipid-Lowering Pharmacotherapy in Central and Eastern European Countries in Cardiovascular Prevention: Self-Reported Prescription Patterns of Primary Care Physicians
submitted by lolirondro 1 year and 8 months ago - Topic: Health
The aims of this study were (1) to explore physicians’ self-reported treatment of patients with dyslipidemia and to identify intercountry differences and associations between physicians’ characteristics and treatment patterns. A cross-sectional survey was performed in primary health care in 9 Central and Eastern European countries. An anonymous questionnaire, which included question...

Type 2 Diabetes Mellitus Management in Canada: Is It Improving?
submitted by napimbreon 1 year and 4 months ago - Topic: Health
To gain insight into the current management of patients with type 2 diabetes mellitus by Canadian primary care physicians. A total of 479 primary care physicians from across Canada submitted data on 5123 type 2 diabetes patients whom they had seen on a single day on or around World Diabetes Day, November 14, 2012. Mean glycated hemoglobin (A1C) was 7.4%, low-density lipoprotein (LDL-C) was 2.1 ...

Lipid-lowering therapy using statins in patients with cardiovascular risk in clinical practice in Thailand
submitted by jaja 1 year and 1 month ago - Topic: Health
Since the release in Thailand in 2001 of the Third Guidelines by the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults or the Adult Treatment Panel (ATP III), there have been no nationwide studies on the proportion of dyslipidaemic patients who have achieved the low-density lipoprotein cholesterol (LDL-C) goals....

Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study)
submitted by camineas 2 years and 5 months ago - Topic: Health
Chronic kidney disease (CKD) is common and increasing in prevalence. Adverse outcomes of CKD can be prevented through early detection and treatment. There is limited data on the awareness of CKD and the quality of care offered to patients with CKD in the primary care setting. The objectives of this study were to assess the prevalence, general practitioner (GP) awareness and extent of current ev...

Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es
submitted by otteke 11 months ago - Topic: Health
Evaluar el patrón de consumo de ocho grupos de fármacos para el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular; identificar en la población española los determinantes sociodemográficos y de salud asociados al consumo de aquellos. El estudio Di@bet.es es una encuesta poblacional transversal que comprende una muestra significativa de la población adulta españ...


Cross-analysis of dietary prescriptions and adherence in 356 hypercholesterolaemic patients
submitted by midenoj 1 year and 10 months ago - Topic: Health
One of the major issues in controlling serum cholesterol through dietetic intervention appears to be the need to improve patient adherence. To explore the many questions regarding barriers to, and motivators for, cholesterol-lowering diet adherence. We surveyed French general practitioners’ dietetic practices for patients with hypercholesterolaemia, and looked at their patients’ attitudes t...

Pharmacological primary and secondary cardiovascular prevention among diabetic patients in a multiethnic general practice population: still room for improvements
submitted by bioagri 1 year and 4 months ago - Topic: Biology
Ethnic minority groups have higher prevalence of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). We assessed general practitioners' (GPs') performance with respect to the pharmacological prevention of CVD in patients with T2DM from different ethnic backgrounds in Oslo. Of 1653 T2DM patients cared for by 49 GPs in 2005, 380 had a diagnosis of CVD. Ethnicity was categorized as N...


Treatment of dyslipidemia in idiopathic inflammatory myositis: results of the International Myositis Assessment and Clinical Studies Group survey
submitted by beacamp 2 years and 3 months ago - Topic: Health
Recent data suggest that atherosclerotic disease is increased in patients with idiopathic inflammatory myositis (IIM) and that dyslipidemia is a significant risk factor for cardiovascular events. Lipid-lowering agents may be associated with myopathic side effects. The current work evaluates the use of lipid-lowering therapy in patients with IIM treated by IIM specialists belonging to the Intern...

Use of Drugs Related to the Treatment of Diabetes Mellitus and Other Cardiovascular Risk Factors in the Spanish Population. The Di@bet.es Study
submitted by majtobo3521 11 months ago - Topic: Health
To assess the patterns of use of 8 therapeutic drug groups for the treatment of diabetes mellitus and other cardiovascular risk factors, and to identify sociodemographic and health determinants of their use in the overall Spanish population. A representative sample of the Spanish population within the Di@bet.es study, a cross-sectional population-based survey, was included. Study variables: soc...

Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey
submitted by rozon 9 months ago - Topic: Health
Previous studies have reported that the attainment of goals for low-density lipoprotein cholesterol (LDL-C) are globally suboptimal, but contemporary data are scarce. The CEntralized Pan-Asian survey on tHE Under-treatment of hypercholeSterolemia (CEPHEUS-PA) is the largest evaluation of pharmacological treatment for hypercholesterolemia in Asia. The study reported here analyzed the Taiwan coho...

Cardiovascular Pharmacogenomics: Expectations and Practical Benefits
submitted by sarish 6 months ago - Topic: Health
Cardiovascular disease is a leading cause of morbidity and mortality worldwide. Pharmacogenomics is the study of genetic determinants of interindividual variation in drug response and aims to facilitate personalized medicine, through genotype-informed drug and dose selection, to maximize drug efficacy and/or minimize adverse drug reactions. Despite high expectations, no cardiovascular pharmacog...

Centralized Pan-European Survey on the Undertreatment of Hypercholesterolemia in Patients Using Lipid Lowering Drugs-The CEPHEUS-Greece Survey
submitted by goleles 4 years and 2 months ago - Topic: Biology
Surveys evaluating plasma lipid goal attainment in patients with coronary heart disease (CHD) show that hypercholesterolemia is inadequately treated. CEPHEUS (CEntralized Pan-European survey on tHE Undertreatment of hypercholeSterolemia)-Greece was part of a European multicenter, cross-sectional survey to evaluate the proportion of patients on lipid-lowering drugs (LLDs) for ≥3 months, witho...

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia: Results From the CEPHEUS Study in Arabian Gulf Countries
submitted by ntgrzych 9 months ago - Topic: Health
The Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia (CEPHEUS) survey evaluated the attainment of low-density lipoprotein cholesterol (LDL-C) goals among patients on lipid-lowering drugs (LLDs) according to the updated National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP-III) guideline. The survey was conducted in 6 Arabian Gulf countries. Pat...

Prediction of Clinical Irrelevance of PK Differences in Atorvastatin Using PK/PD Models Derived From Literature-Based Meta-Analyses
submitted by sarish 3 months ago - Topic: Health
To support the development of a fixed-dose combination (FDC) of ezetimibe and atorvastatin for the treatment of dyslipidemia, bioequivalence (BE) studies were conducted across a combined dose range (10/10, 10/20, 10/40, and 10/80 mg of ezetimibe/atorvastatin). In the BE trials, all parameters met traditional BE bounds except for atorvastatin peak plasma concentration (Cmax) at two interm...

Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes
submitted by takedake92 10 months ago - Topic: Health
To assess the relationship of patients' medication beliefs and treatment complexity with unintentional and intentional non-adherence for three therapeutic groups commonly used by patients with type 2 diabetes. Survey data about adherence (Medication Adherence Report Scale) and beliefs about medicines (Beliefs about Medicines Questionnaire) were combined with prescription data from the Groningen...

Effects of xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study
submitted by rozon44 4 days ago - Topic: Health
Xuezhikang (XZK) is an extract of fermented red yeast rice that has lipid-lowering properties. To evaluate the effects of XZK on lipids in subjects with dyslipidemia but no coronary heart disease. One hundred sixteen adults with baseline non−high-density lipoprotein cholesterol (non−HDL-C) levels of approximately 208 mg/dL and low-density lipoprotein cholesterol (LDL-C) levels of approximat...